Q1 FY27 Business Update: Revenue 99.60 Cr, 50% of FY26 full-year
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Chemkart India reported Q1 FY27 revenue of INR 9,960.22 lakhs (99.60 crore), nearly 50% of the previous full year's revenue with improved margins. Subsidiary Vinstar Biotech received trial orders for in-house value-added ingredients, the group's first proprietary formulations. EZRM manufacturing facility is on schedule, with civil work, electricity sanction and packaging machinery finalized. 15 new key customers added, 20 R&D projects in pipeline. Company is evolving from distributor to integrated solutions partner.
Strong Q1 execution at 50% of FY26 full-year revenue signals strong momentum. Subsidiary trial orders and EZRM progress expand future growth potential.